- $17.40m
- $16.64m
- $25.00m
- 23
- 66
- 37
- 37
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 35.9 | 33.4 | 28.3 | 24.4 | 25 |
Cost of Revenue | |||||
Gross Profit | 13.6 | 12.5 | 10.8 | 11.6 | 11.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 41.4 | 38.1 | 34.2 | 20.6 | 27.4 |
Operating Profit | -5.54 | -4.66 | -5.96 | 3.83 | -2.35 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.77 | -4.78 | -6.19 | 3.76 | -2.38 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.8 | -4.79 | -6.22 | 3.74 | -2.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.71 | -4.71 | -6.15 | 3.7 | -2.45 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.71 | -4.71 | -6.15 | 3.7 | -2.45 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.115 | -0.121 | -0.166 | 0.017 | -0.099 |